Early detection of Alzheimer disease: 11C-PiB PET in twins discordant for cognitive impairment

Neurology

Volumn 77, Issue 5, 2011, Pages 453-460

  Scheinin, N M ^a   Aalto, S ^a,c   Kaprio, J ^d,e   Koskenvuo, M ^d   Raiha I Z ^b   Rokka, J ^a   Hinkka Yli Salomaki S ^b   Rinne, J O ^a  

^a TURKU PET CENTRE   (Finland)

^b Department of Family Practice ^*  (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d ÅBO AKADEMI UNIVERSITY   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN MAPPING; CEREBELLUM; CLINICAL ARTICLE; CLINICAL PROTOCOL; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIZYGOTIC TWINS; DRUG UPTAKE; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; MONOZYGOTIC TWINS; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CINGULATE; PRIORITY JOURNAL;

EID: 80051528489     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318225118e     Document Type: Article

References (36)

1. Green R, Cupples L, Go R, et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA 2002;287:329-336. (Pubitemid 34251966)
2. Räihä I, Kaprio J, Koskenvuo M, Rajala T, Sourander L. Alzheimer's disease in Finnish twins. Lancet 1996;347: 573-578. (Pubitemid 26070739)
3. Pedersen N, Gatz M, Berg S, Johansson B. How heritable is Alzheimer's disease late in life? Findings from Swedish twins. Ann Neurol 2004;55:180-185. (Pubitemid 38166994)
4. Gatz M, Reynolds C, Fratiglioni L, et al. Role of genes and environments for explaining Alzheimer's disease. Arch Gen Psychiatry 2006;63:168-174. (Pubitemid 43213878)
5. Cook R, Schneck S, Clark D. Twins with Alzheimer's disease. Arch Neurol 1981;38:300-301. (Pubitemid 11106535)
6. Brickell K, Leverenz J, Steinbart E, et al. Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007;78:1050-1055.
7. Järvenpää T, Räihä I, Kaprio J, et al. Regional cerebral glucose metabolism in monozygotic twins discordant for Alzheimer's disease. Dement Geriatr Cogn Disord 2003; 16:245-252. (Pubitemid 37188120)
8. Virta J, Aalto S, Järvenpää T, et al. Voxel-based analysis of cerebral glucose metabolism in mono- and dizygotic twins discordant for Alzheimer disease. J Neurol Neurosurg Psychiatry 2009;80:259-266.
9. Virta J, Karrasch M, Kaprio J, et al. Cerebral glucose metabolism in dizygotic twin pairs discordant for Alzheimer's disease. Dement Geriatr Cogn Disord 2008;25:9-16. (Pubitemid 350308381)
10. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82: 239-259.
11. Price J, Morris J. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease Ann Neurol 1999;45:358-368. (Pubitemid 29120041)
12. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-319. (Pubitemid 38269583)
13. Kemppainen N, Aalto S, Wilson I, et al. Voxel-based analysis of PET amyloid ligand [11C]PiB uptake in Alzheimer disease. Neurology 2006;67:1575-1580. (Pubitemid 44747926)
14. Rabinovici G, Furst A, O'Neil J, et al. 11C-PiB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 2007;68:1205-1212. (Pubitemid 46608468)
15. Rowe C, Ng S, Ackermann U, et al. Imaging beta-amyloid burden in aging and dementia. Neurology 2007;68:1718-1725. (Pubitemid 46763260)
16. Edison P, Rowe C, Rinne JO, et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PiB positron emission tomography. J Neurol Neurosurg Psychiatry 2008;79:1331-1338.
17. Gomperts S, Rentz D, Moran E, et al. Imaging amyloid deposition in Lewy body diseases. Neurology 2008;71: 903-910.
18. Koivunen J, Verkkoniemi A, Aalto S, et al. PET amyloid ligand [11C]PiB uptake shows predominantly striatal increase in variant Alzheimer's disease. Brain 2008;131: 1845-1853. (Pubitemid 351957460)
19. Villemagne V, McLean C, Reardon K, et al. 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2009;80:998-1001.
20. Kaprio J, Koskenvuo M. Genetic and environmental factors in complex diseases: the older Finnish Twin Cohort. Twin Res 2002;5:358-365. (Pubitemid 35315484)
21. Järvenpää T, Rinne J, Räihä I, et al. Characteristics of two telephone screens for cognitive impairment. Dement Geriatr Cogn Disord 2002;13:149-155. (Pubitemid 34224934)
22. Aalto S, Scheinin NM, Kemppainen N, et al. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PiB uptake using 30-min scanning data. Eur J Nucl Med Mol Imaging 2009;36:1651-1660.
23. Scheinin NM, Aalto S, Koikkalainen J, et al. Follow-up of [11C]PiB uptake and brain volume in patients with Alzheimer disease and controls. Neurology 2009;73:1186-1192.
24. Aizenstein H, Nebes R, Saxton J, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 2008;65:1509-1517.
25. Jack CR, Lowe VJ, Senjem ML, et al. C-11 PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment. Brain 2008;131:665-680. (Pubitemid 351294719)
26. Reiman E, Chen K, Liu X, et al. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 2009; 106:6820-6825.
27. Klunk WE, Price JC, Mathis CA, et al. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 2007;27: 6174-6184. (Pubitemid 46890033)
28. Remes A, Laru L, Tuominen H, et al. Carbon 11-labeled Pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication. Arch Neurol 2008;65:540-544. (Pubitemid 351549966)
29. Järvenpää T, Laakso M, Rossi R, et al. Hippocampal MRI volumetry in cognitively discordant monozygotic twin pairs. J Neurol Neurosurg Psychiatry 2004;75:116-120. (Pubitemid 38091279)
30. Reiman E, Caselli R, Yun L, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996;334: 752-758. (Pubitemid 26089356)
31. Mosconi L, Brys M, Switalski R, et al. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci USA 2007;104: 19067-19072.
32. Li Y, Rinne J, Mosconi L, et al. Regional analysis of FDG and PiB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging 2008;35:2169-2181.
33. Pike KE, Savage G, Villemagne VL, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007;130: 2837-2844. (Pubitemid 350033975)
34. Villemagne V, Pike K, Darby D, et al. Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia 2008;46:1688-1697.
35. Engler H, Forsberg A, Almkvist O, et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 2006;129:2856-2866. (Pubitemid 44684508)
36. Price J, McKeel DJ, Buckles V, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 2009;30:1026-1036.